Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Core EBITDA Growth

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 38.4919.51365.23-83.7020.61

What is the latest Core EBITDA Growth ratio of STRIDES PHARMA SCIENCE ?

The latest Core EBITDA Growth ratio of STRIDES PHARMA SCIENCE is 38.49 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202538.49
Mar202419.51
Mar2023365.23
Mar2022-83.70
Mar202120.61

How is Core EBITDA Growth of STRIDES PHARMA SCIENCE Trending?

Years Core EBITDA Growth % Change
Mar2025 38.49
97.28
Mar2024 19.51
-94.66
Mar2023 365.23
Positive
Mar2022 -83.7
Negative
Mar2021 20.61 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare Core EBITDA Growth ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹9,873.7 Cr 7% 19.3% 53.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,052.0 Cr 0.3% -3.7% -4.7% Stock Analytics
DIVIS LABORATORIES ₹169,336.0 Cr 2.4% 6.7% 11.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,311.0 Cr -0.8% -1.5% 25.4% Stock Analytics
DR REDDYS LABORATORIES ₹111,264.0 Cr 7.9% 4.6% 4.6% Stock Analytics
CIPLA ₹105,484.0 Cr 5.5% 5.4% -18.5% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

7%

19.3%

53.5%

SENSEX

-0.4%

1.3%

0.8%


You may also like the below Video Courses